SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Jun-23 4:09 PM View: | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 18% 28.42K to 33.57K | |
28-May-21 4:16 PM View: | Esperion Therapeutics, Inc. (ESPR) | 27-May-21 | Grant | 12,376 | -- | -- | 77% 16.04K to 28.42K | |
29-May-20 4:36 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-May-20 | Grant | 6,106 | -- | -- | 61% 9.93K to 16.04K | |
31-May-19 4:52 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-May-19 | Grant | 9,934 | -- | -- | 100% 0 to 9.93K | |
26-Mar-18 6:54 PM View: | Aravive, Inc. (ARAV) | 23-Mar-18 | Market Sale | 4,345 | $1.75 | $7,603.75 | (2%) 220.1K to 215.75K | 40% |
22-Dec-17 5:16 PM View: | Aravive, Inc. (ARAV) | 20-Dec-17 | Grant | 93,100 | -- | -- | 73% 127.0K to 220.1K | |
10-Oct-17 8:20 PM View: | Aravive, Inc. (ARAV) | 06-Oct-17 | Grant | 82,000 | -- | -- | 182% 45.0K to 127.0K | |
31-Mar-17 5:35 PM View: | Aravive, Inc. (ARAV) | 22-Mar-17 | Grant | 45,000 | -- | -- | 100% 0 to 45.0K |